Belite Bio Stock (NASDAQ: BLTE) stock price, news, charts, stock research, profile.
Open | $42.500 |
Close | $42.500 |
Volume / Avg. | 22.084K / 40.975K |
Day Range | 42.000 - 42.800 |
52 Wk Range | 11.000 - 48.600 |
Market Cap | $1.131B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 59 |
Short Interest | 0.29% |
Days to Cover | 1.24 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Belite Bio (NASDAQ: BLTE) through any online brokerage.
Other companies in Belite Bio’s space includes: Supernus Pharmaceuticals (NASDAQ:SUPN), Verona Pharma (NASDAQ:VRNA), WAVE Life Sciences (NASDAQ:WVE), Tarsus Pharmaceuticals (NASDAQ:TARS) and Phibro Animal Health (NASDAQ:PAHC).
The latest price target for Belite Bio (NASDAQ: BLTE) was reported by HC Wainwright & Co. on Friday, March 22, 2024. The analyst firm set a price target for 59.00 expecting BLTE to rise to within 12 months (a possible 55.26% upside). 14 analyst firms have reported ratings in the last year.
The stock price for Belite Bio (NASDAQ: BLTE) is $38 last updated April 26, 2024 at 8:29 AM EDT.
There are no upcoming dividends for Belite Bio.
Belite Bio’s Q2 earnings are confirmed for Tuesday, August 6, 2024.
There is no upcoming split for Belite Bio.
Belite Bio is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.